ALERGINIŲ SUSIRGIMŲ DIAGNOSTIKOS IR GYDYMO CENTRAS, UAB - financials and debts
Company age: 26 y. 7 mo.
ALERGINIŲ SUSIRGIMŲ DIAGNOSTIKOS IR GYDYMO CENTRAS - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 62,264 | 69,123 | 56,846 | 67,347 | 76,251 | 90,393 | 97,023 | 106,407 |
| Profit before tax | - | - | - | 2,791 | 786 | 1,312 | 2,824 | 3,446 |
| Net profit | -201 | 450 | 180 | 2,348 | 662 | 1,115 | 2,377 | 2,895 |
| Equity | -6,881 | -6,431 | -6,252 | -3,904 | -3,242 | -2,126 | 251 | 3,148 |
| Liabilities | 13,822 | 13,663 | 15,251 | 14,720 | 14,879 | 13,405 | 11,816 | 10,440 |
| Non-current assets | 137 | 69 | 36 | 12 | 12 | 12 | 12 | 12 |
| Current assets | 6,075 | 6,434 | 8,234 | 10,075 | 10,896 | 10,538 | 11,326 | 12,847 |
| Total assets | 6,212 | 6,503 | 8,270 | 10,087 | 10,908 | 10,550 | 11,338 | 12,859 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 4,006 | 4,027 | 4,598 |
| Social insurance contributions | - | - | - | - | - | 6,161 | 6,428 | 7,489 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -11.1% | +11.0% | -17.8% | +18.5% | +13.2% | +18.5% | +7.3% | +9.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -3.2% | 6.9% | 2.2% | 23.3% | 6.1% | 10.6% | 21.0% | 22.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | - | 947.0% | 92.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -0.3% | 0.7% | 0.3% | 3.5% | 0.9% | 1.2% | 2.4% | 2.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | 4.1% | 1.0% | 1.5% | 2.9% | 3.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - | 47.1 | 3.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 7,783 | 8,640 | 7,106 | 8,418 | 10,765 | 12,913 | 13,230 | 13,301 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
ALERGINIŲ SUSIRGIMŲ DIAGNOSTIKOS IR GYDYMO CENTRAS - Social security debts
The company had no debts to Sodra
ALERGINIŲ SUSIRGIMŲ DIAGNOSTIKOS IR GYDYMO CENTRAS - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
ALERGINIU SUSIRGIMU DIAGNOSTIKOS IR GYDYMO CENTRAS, UAB is a Private Limited Liability Company engaged in medical specialists activities. In 2025, the company generated revenue of €106.4K, up 9.7% year on year and 17.7% over two years. Net profit increased to €2.9K, while the profit margin improved to 2.7% from 2.4% in 2024 and 1.2% in 2023. The three-year trend shows steady growth in both turnover and earnings, with revenue rising from €90.4K in 2023 to €97.0K in 2024 and then to the latest level in 2025. The balance sheet remained compact, with total assets of €12.9K and liabilities of €10.4K at year-end 2025. Equity strengthened to €3.1K from €251 in 2024 and a negative €2.1K in 2023, indicating an improved capital position. Asset turnover was 8.27x, reflecting high use of assets in generating revenue. Revenue per employee was €13.3K, and profit per employee was €362, pointing to a modest operating scale despite the positive profitability trend.